Tolerance to aggregated human IgG but not ovalbumin can be induced by concurrent administration of depleting or non‐depleting anti‐L3T4 monoclonal antibodies
- 1 February 1989
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 67 (1) , 1-7
- https://doi.org/10.1038/icb.1989.1
Abstract
Tolerance to soluble antigens has previously been shown to occur in mice if anti-L3T4 monoclonal antibody (MoAb) is administered al the time of antigen exposure. The process of tolerance induction may require the depletion of L3T4+ cells or it may be due to down-regulation or negative signaling of L3T4+ cells. We compared the effects of L3T4+ cell depletion and L3T4 antigen blockade at the time of primary antigen challenge on long-term humoral responses. Anti-L3T4 MoAb GK1·5 (IgG2b) and H129·19 (IgG2a) were used to deplete or block, respectively. L3T4+ cells. Following a short course of MoAb and antigen challenge with both aggregated human IgG (ag-HGG) and ovalbumin (OVA) in each mouse, primary response titres to each antigen in both MoAb treated groups were ∼1:102 compared with ∼1:105 in control mice. Repeated antigen challenge significantly increased the anti-OVA titre in both MoAb treated groups and by 150 days they were similar to controls. However, anti-HGG titres did not increase significantly in either of the MoAb treated groups. Thus either depletion of peripheral L3T4+ cells, or blockade of the L3T4 antigen without depletion of peripheral L3T4+ cells, can invoke a state of long-term antigen-specific tolerance to some antigens. Why the effect is restricted to particular antigens, and the exact mechanisms of tolerance induction remain to be determined.Keywords
This publication has 23 references indexed in Scilit:
- Involvement of the CD4 molecule in a post‐activation event on T cell proliferationEuropean Journal of Immunology, 1987
- REJECTION OF SKIN GRAFTS AND GENERATION OF CYTOTOXIC T CELLS BY MICE DEPLETED OF L3T4+ CELLSTransplantation, 1986
- Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.The Journal of Experimental Medicine, 1986
- Tolerance to rat monoclonal antibodies. Implications for serotherapy.The Journal of Experimental Medicine, 1986
- Induction of tolerance by monoclonal antibody therapyNature, 1986
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- Cellular Mechanisms of Immunologic ToleranceAnnual Review of Immunology, 1983
- The Lyt‐2, Lyt‐3 Macromolecules: Structural and Functional StudiesImmunological Reviews, 1982